Glycogen Storage Disease Iii (GSD3)

Alias:

Glycogen Storage Disease Type Iii

Forbes Disease

Glycogen Storage Disease Iiia

Cori Disease

Amylo-1,6-Glucosidase Deficiency

Glycogen Storage Disease Iiib

Limit Dextrinosis

Gde Deficiency

Glycogen Storage Disease Iiic

Glycogenosis Type Iii

Agl Deficiency

Gsd3

Glycogen Storage Disease Due to Glycogen Debranching Enzyme Deficiency

Glycogenosis Due to Glycogen Debranching Enzyme Deficiency

Gsd Due to Glycogen Debranching Enzyme Deficiency

Glycogen Storage Disease Type 3

Glycogen Debrancher Deficiency

Glycogen Storage Disease Iiid

Glycogen Storage Disease 3

Debrancher Deficiency

Cori-Forbes Disease

Glycogenosis Type 3

Gsd Type 3

Gsdiii

Glycogen Debranching Enzyme Deficiency

Storage Disease, Glycogen, Type Iii

Glycogen Storage Disease, Type Iii

Amylo 1,6 Glucosidase Deficiency

Deficiency of Debranching Enzyme

Deficiency of Dextrin

Cori's Disease

Gsd Iiia

Gsd Iiib

Gsd Iiic

Gsd Iiid

Gsd Iii

Gsd-Iii

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Glycogen Storage Disease Iii, also known as glycogen storage disease type iii, is related to glycogen storage disease due to glucose-6-phosphatase deficiency and atrial standstill 1. An important gene associated with Glycogen Storage Disease Iii is AGL (Amylo-Alpha-1, 6-Glucosidase, 4-Alpha-Glucanotransferase), and among its related pathways/superpathways are Infectious disease and Metabolism. The drugs Ibuprofen and Acetaminophen have been mentioned in the context of this disorder. Affiliated tissues include liver and heart, and related phenotypes are short stature and intellectual disability, mild

Related ID：

MALACARDS：GLY003

OMIM：232400

MESH：D006010